IDEXX Laboratories, Inc. (IDXX), valued at a market cap of almost $35 billion, develops, manufactures, and distributes products mainly for the companion animal veterinary, livestock and poultry ...
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 fourth quarter and full year financial results for Monday, February 3 ...
Shares of IDEXX Laboratories Inc. IDXX shed 0.94% to $418.63 Tuesday, on what proved to be an all-around positive trading ...
While IDEXX Laboratories, Inc. (NASDAQ:IDXX) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 21% in the last quarter.
Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks An announcement from Idexx Laboratories ( (IDXX)) is now available. IDEXX Laboratories has approved a ...
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that the Company’s Board of Directors authorized an ...
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 fourth quarter and full year financial results for Monday, February 3, 2025 ...
WESTBROOK, Maine, January 16, 2025--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 fourth quarter and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback